UBS O'Connor’s Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 PIAI.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-252,838
Closed -$138K 443
2021
Q4
$138K Sell
252,838
-13,818
-5% -$9.94K ﹤0.01% 786
2021
Q3
$183K Hold
266,656
﹤0.01% 732
2021
Q2
$279K Hold
266,656
﹤0.01% 677
2021
Q1
$224K Buy
+266,656
New +$403K ﹤0.01% 673

Other funds holding PIAI.WS

UBS O'Connor's PIAI.WS Position: Q1 2022 in Review

UBS O'Connor sold out of Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (PIAI.WS) in Q1 2022, closing a stake of 252,838 shares — an estimated $138K sold.

UBS O'Connor first reported a position in PIAI.WS in Q1 2021 and held it in 4 quarters. The position peaked at $279K in Q2 2021. 29 funds tracked by Wall St. Rank hold PIAI.WS as of Q1 2022.

  • UBS O'Connor reported no remaining Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2022 after selling out during the quarter.
  • UBS O'Connor sold 252,838 Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2022, an estimated $138K.
  • UBS O'Connor first reported a position in Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2021 and held it in 4 quarters.
  • UBS O'Connor's Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $279K in Q2 2021.
  • 29 funds tracked by Wall St. Rank held Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2022.

Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.